<DOC>
	<DOCNO>NCT00246623</DOCNO>
	<brief_summary>This study examine dose Exubera ( inhaled insulin ) patient well control two diabetes pill . This study show large number patient enrol study reach target Hemoglobin A1C level ( 7 % less ) set American Diabetes Association ( ADA ) . Target goal achieve adjust Exubera dose either weekly twice weekly . Patients also receive nutritional counseling diabetes education part study .</brief_summary>
	<brief_title>US Inhaled Insulin Dose Titration Study</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<mesh_term>Insulin</mesh_term>
	<mesh_term>Hypoglycemic Agents</mesh_term>
	<criteria>Male female , age &gt; = 18 year &lt; = 80 year , diagnosis type 2 diabetes make least 6 month prior study entry , hemoglobin A1C 7.510 % Currently treat 2 oral antidiabetic agent ( sulfonylurea , metformin , and/or thiazolidinediones ) Type 1 diabetes Smoking within past 6 month significant pulmonary disease</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>May 2007</verification_date>
</DOC>